CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

Lee, Sungho, Varvel, Nicholas H., Konerth, Megan E., Xu, Guixiang, Cardona, Astrid E., Ransohoff, Richard M., Lamb, Bruce T.·2010·The American Journal of Pathology

Cited by (510)

Items 201–300 of 510

  1. MyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease
    Lim, Jeong-Eun, Kou, Jinghong, Song, Min, Pattanayak, Abhinandan, Jin, Jingji, Lalonde, Robert, Fukuchi, Ken-ichiro · 2011 · The American Journal of Pathology
  2. Mouse models of Alzheimer’s disease cause rarefaction of pial collaterals and increased severity of ischemic stroke
    Hua Zhang, Bo Jin, James E. Faber · 2018 · Angiogenesis
  3. Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
    Brad T. Casali, Erin G. Reed-Geaghan · 2021 · Cells
  4. Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency
    Jiang Wu, Bihua Bie, Hui Yang, Jijun J. Xu, David L. Brown, Mohamed Naguib · 2013 · Neurobiology of Aging
  5. Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice
    Hayley A. Mattison, Hui Nie, Hui‐Ming Gao, Hui Zhou, Jau‐Shyong Hong, Jing Zhang · 2013 · Journal of Neuroimmunology
  6. A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress
    Lianne Hoeijmakers, Sylvie L. Lesuis, Harm J. Krugers, Paul John Lucassen, Anikó Kőrösi · 2018 · Neurobiology of Stress
  7. Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction
    Fan, Qingyuan, He, Wanxia, Gayen, Manoshi, Benoit, Marc Robert, Luo, Xiaoyang, Hu, Xiangyou, Yan, Riqiang · 2020 · The Journal of Neuroscience
  8. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: suppression by curcumin
    Xu, Min-Xuan, Yu, Rong, Shao, Li-Fei, Zhang, Yan-Xiu, Ge, Chen-Xu, Liu, Xin-Meng, Wu, Wen-Yuan, Li, Jian-Mei, Kong, Ling-Dong · 2016 · Brain Behavior and Immunity
  9. 5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer’s Disease
    Zahra Manji, Asheebo Rojas, Wenyi Wang, Raymond J Dingledine, Nicholas H. Varvel, Thota Ganesh · 2019 · Journal of Alzheimer s Disease
  10. GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer’s disease
    Julie Audoy-Rémus, Lusiné Bozoyan, Aline Dumas, Mohammed Filali, Cynthia Lecours, Steve Lacroix, Serge Rivest, Marie‐Ève Tremblay, Luc Vallières · 2015 · Brain Behavior and Immunity
  11. Aging, depression and dementia: The inflammatory process
    María Pilar Carrera-González, Vanesa Cantón-Habas, Manuel Rich‐Ruiz · 2022 · Advances in Clinical and Experimental Medicine
  12. Therapeutic potential of the chemokine–receptor duo fractalkine/CX3CR1: an update
    Jan Goesta D’Haese, Helmut Friess, Guralp Onur Ceyhan · 2012 · Expert Opinion on Therapeutic Targets
  13. The impact of neuroimmune changes on development of amyloid pathology; relevance to A lzheimer's disease
    Marina A. Lynch · 2013 · Immunology
  14. Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death
    Maria Rosito, C. Lauro, Giuseppina Chece, A. Porzia, L. Monaco, F. Mainiero, M. Catalano, C. Limatola, F. Trettel · 2014 · Frontiers in Cellular Neuroscience
  15. Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
    Anna Rita Zuena, Paola Casolini, Roberta Lattanzi, Daniela Maftei · 2019 · Frontiers in Pharmacology
  16. Microglial TNF-α-Dependent Elevation of MHC Class I Expression on Brain Endothelium Induced by Amyloid-Beta Promotes T Cell Transendothelial Migration
    Yang, Yi-Ming, Shang, De-Shu, Zhao, Wei-Dong, Fang, Wen-Gang, Chen, Yu-Hua · 2013 · Neurochemical Research
  17. Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?
    Melanie Meyer‐Luehmann, Marco Prinz · 2015 · Trends in Neurosciences
  18. Genetic manipulation of microglia during brain development and disease
    Peter Wieghofer, Marco Prinz · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  19. Review: Experimental manipulations of microglia in mouse models of <scp>A</scp>lzheimer's pathology: activation reduces amyloid but hastens tau pathology
    Lee, D. C., Rizer, J., Hunt, J. B., Selenica, M.‐L. B., Gordon, M. N., Morgan, D. · 2013 · Neuropathology and Applied Neurobiology
  20. Behavioral and neuropsychiatric disorders in Alzheimer's disease
    Cortés, Nicole, Andrade, Víctor, Maccioni, Ricardo B. · 2018 · Journal of Alzheimer's Disease
  21. Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging
    Primiani, Christopher T., Ryan, Veronica H., Rao, Jagadeesh S., Cam, Margaret C., Ahn, Kwangmi, Modi, Hiren R., Rapoport, Stanley I. · 2014 · PLoS ONE
  22. Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
    Maiara N. Lima, Maria Carolina Barbosa‐Silva, Tatiana Maron‐Gutierrez · 2022 · Frontiers in Cellular Neuroscience
  23. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis
    Dariusz Szukiewicz · 2024 · International Journal of Molecular Sciences
  24. Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids
    Roberta Gualtierotti, Laura Guarnaccia, Matteo Beretta, Stefania Elena Navone, Rolando Campanella, Laura Riboni, Paolo Maria Rampini, Giovanni Marfia · 2017 · Advances in Therapy
  25. Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy
    Jerry B. Hunt, Kevin R. Nash, Devon S. Placides, Peter Moran, Maj‐Linda B. Selenica, Firas Abuqalbeen, Kevin Ratnasamy, Nina Slouha, Santiago Rodriguez Ospina, Miloni Savlia et al. · 2015 · Journal of Neuroscience
  26. Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
    Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa, Arvind Kumar, Krisztián Szigeti, Domokos Máthé, Balázs Zoltán Gulyás, Govindaraju Archunan, Parasuraman Padmanabhan · 2021 · Biomedicines
  27. The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer’s amyloid pathology
    Qingyuan Fan, Manoshi Gayen, Neeraj Singh, Fan Gao, Wanxia He, Xiangyou Hu, Li‐Huei Tsai, Riqiang Yan · 2019 · The Journal of Experimental Medicine
  28. Chronic acrylamide exposure induced glia cell activation, NLRP3 infl-ammasome upregulation and cognitive impairment
    Ying Liu, Xing Zhang, Dandan Yan, Yiqi Wang, Na Wang, Yufan Liu, Aijun Tan, Xiaoyi Chen, Hong Yan · 2020 · Toxicology and Applied Pharmacology
  29. The Effects of Age and Cx 3 cr1 Deficiency on Retinal Microglia in the Ins2 Akita Diabetic Mouse
    Jelena Marie Kezic, Xiangting Chen, Elizabeth Piroska Rakoczy, Paul Gerard McMenamin · 2013 · Investigative Ophthalmology & Visual Science
  30. Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration
    M. Al-Onaizi, Alaa B. Alkhalifah, Dalal Qasem, A. ElAli · 2020 · International Journal of Molecular Sciences
  31. Neuron-macrophage crosstalk in the intestine: a “microglia” perspective
    Simon Verheijden, Sebastiaan De Schepper, Guy E. Boeckxstaens · 2015 · Frontiers in Cellular Neuroscience
  32. Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
    Neira Polet Camacho-Hernández, Fernando Peña‐Ortega · 2023 · Neural Plasticity
  33. Development and characterization of a human microglia cell model of HIV-1 infection
    Pratima Rawat, Stephen A. Spector · 2016 · Journal of NeuroVirology
  34. Higher Plasma Fractalkine Is Associated With Better 6-Month Outcome From Ischemic Stroke
    Donohue, Megan M., Cain, Kevin, Zierath, Dannielle, Shibata, Dean, Tanzi, Patricia M., Becker, Kyra J. · 2012 · Stroke
  35. Mechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cells
    Monique Michels, Amanda Valnier Steckert, João Quevedo, Tatiana Barichello, Felipe Dal‐Pizzol · 2015 · Intensive Care Medicine Experimental
  36. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey L. Cummings, Andrew Adonay Ortiz, Janelle Castellino, Jefferson W. Kinney · 2022 · European Journal of Neuroscience
  37. Current tools to interrogate microglial biology
    Anaelle Aurelie Dumas, Katharina Borst, Marco Prinz · 2021 · Neuron
  38. The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
    Shi-Ting Weng, Qi‐Lun Lai, Junjun Wang, Liying Zhuang, Lin Cheng, Yejia Mo, Lu Liu, Zexian Zhao, Ying Zhang, Song Qiao · 2022 · Frontiers in Aging Neuroscience
  39. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model
    C. Kong, Eun-Jeong Yang, Jaewoo Shin, Junwon Park, Si-Hyun Kim, Seong-wook Park, W. Chang, Chang-Han Lee, H. Kim, H. Kim et al. · 2022 · Translational Neurodegeneration
  40. Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis
    Mariko Noda, Akio Suzumura · 2012 · International Journal of Alzheimer s Disease
  41. CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer’s disease
    Lihang Zhang, Juan Xu, Jinchao Gao, Yun‐Cheng Wu, Ming Yin, Wenjuan Zhao · 2018 · Reviews in the Neurosciences
  42. Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer’s Disease
    Wenhao Huang, Qing Xia, Feifei Zheng, Xue Ling Zhao, Fangliang Ge, Jiaying Xiao, Zijie Liu, Ying‐Ying Shen, Ke Ye, Dayong Wang et al. · 2023 · Journal of Alzheimer s Disease
  43. Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology
    Zui Zhang, Yoshiko Takeda‐Uchimura, Tahmina Foyez, Shiori Ohtake‐Niimi, Narentuya, Hiroyasu Akatsu, Kazuchika Nishitsuji, Makoto Michikawa, Tony Wyss‐Coray, Kenji Kadomatsu et al. · 2017 · Proceedings of the National Academy of Sciences
  44. Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
    Golde, Todd E. · 2019 · Neuron
  45. Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration
    Zach Dwyer, Chris Rudyk, Ashley Thompson, Kyle Farmer, Barbara M. Fenner, Teresa Fortin, Alexa Derksen, Hongyu Sun, Shawn P. Hayley · 2020 · Neurobiology of Aging
  46. A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis
    Guozhao Chen, Zhiping Zhou, Weiping Sha, Liming Wang, Fei Yan, Xiaomei Yang, Xia Qin, Muyao Wu, Di Li, Shoujin Tian et al. · 2020 · International Journal of Molecular Medicine
  47. Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
    Takatori, Sho, Wang, Wenbo, Iguchi, Akihiro, Tomita, Taisuke · 2019 · Advances in Experimental Medicine and Biology
  48. Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure
    Edoardo Brandi, Laura Torres-Garcia, Alexander Svanbergsson, Caroline Haikal, Di Liu, Wen Li, Jiayi Li · 2022 · Frontiers in Aging Neuroscience
  49. Alzheimer’s genes in microglia: a risk worth investigating
    Ari Sudwarts, Gopal Thinakaran · 2023 · Molecular Neurodegeneration
  50. The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases
    Triviño, Juan José, von Bernhardi, Rommy · 2021 · Neurochemistry International
  51. Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline
    M. González-Prieto, I. L. Gutiérrez, B. García-Bueno, J. Caso, J. Leza, A. Ortega-Hernández, D. Gómez-Garre, J. Madrigal · 2020 · Glia
  52. Neuroinflammation in Prion Disease
    Bei Li, Meiling Chen, Caihong Zhu · 2021 · International Journal of Molecular Sciences
  53. Fibrillar Amyloid Plaque Formation Precedes Microglial Activation
    Christian K. E. Jung, Kevin Keppler, Sonja Steinbach, Lidia Blázquez‐Llorca, Jochen Wolfgang Herms · 2015 · PLoS ONE
  54. Microglial functional alteration and increased diversity in the challenged brain: Insights into novel targets for intervention
    Tremblay, Marie-Ève · 2021 · Brain, Behavior, &amp; Immunity - Health
  55. The innate and adaptive immunological aspects in neurodegenerative diseases
    Maria C.O. Rodrigues, Paul R. Sanberg, Luis Eduardo Girón Cruz, Svitlana N. Garbuzova-Davis · 2013 · Journal of Neuroimmunology
  56. Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
    Christiana Bjorkli, Axel Sandvig, Ioanna Sandvig · 2020 · Frontiers in Aging Neuroscience
  57. Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?
    Anastasia Geladaris, Darius Häusler, Martin S. Weber · 2021 · International Journal of Molecular Sciences
  58. Laminin-Dependent Interaction between Astrocytes and Microglia
    Saptarshi Biswas, Galina Bachay, Julianne Chu, Dale D. Hunter, William J. Brunken · 2017 · American Journal Of Pathology
  59. CX3CR1 deficiency exacerbates neuronal loss and impairs early regenerative responses in the target-ablated olfactory epithelium
    Linda V. Blomster, Jana Vukovic, Debbie A.E. Hendrickx, Steffen Jung, Alan R. Harvey, Luis Filgueira, Marc Jan Ruitenberg · 2011 · Molecular and Cellular Neuroscience
  60. Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APPSwe/PS1 mice
    Gaëlle Naert, Serge Rivest · 2012 · Frontiers in Cellular Neuroscience
  61. Galectin-3 aggravates microglial activation and tau transmission in tauopathy
    Jian Jing Siew, Hui-Mei Chen, Feng‐Lan Chiu, Chia‐Wei Lee, Yao‐Ming Chang, Hung-Lin Chen, Thi Ngoc Anh Nguyen, Hung-Ting Liao, Mengyu Liu, Hsiao‐Tien Chien Hagar et al. · 2023 · Journal of Clinical Investigation
  62. Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer’s disease
    Miguel Angel Abellanas, Maitreyee Purnapatre, Chiara Burgaletto, Michal Schwartz · 2025 · Nature Neuroscience
  63. T he microglial reaction signature revealed by RNA seq from individual mice
    Hélène Hirbec, Camille Marmai, Isabelle Duroux-Richard, Christine Roubert, A. Esclangon, Séverine Croze, Joël Lachuer, Ronan Peyroutou, François Rassendren · 2018 · Glia
  64. Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation
    Jing Xu, Tao Yu, Enrica Caterina Pietronigro, Jia Yuan, Jessica Arioli, Yifei Pei, Xuan Luo, Jialin Ye, Gabriela Constantin, Chaoming Mao et al. · 2020 · PLoS Biology
  65. Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress
    Giuseppe Caruso, Cristina Benatti, Nicolò Musso, Claudia Giuseppina Fresta, Annamaria Fidilio, Giorgia Spampinato, Nicoletta Brunello, Claudio Bucolo, Filippo Drago, Susan M. Lunte et al. · 2021 · Biomedicines
  66. Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
    Chloe McKee, Madison Hoffos, Haley A. Vecchiarelli, Marie‐Ève Tremblay · 2023 · Frontiers in Pharmacology
  67. Cytokine Signalling at the Microglial Penta-Partite Synapse
    Aramideh, Jason Abbas, Vidal-Itriago, Andres, Morsch, Marco, Graeber, Manuel B. · 2021 · International Journal of Molecular Sciences
  68. Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer’s Disease
    A López-López, Ellen Gelpí, Diana M. Lopategui, Jose Manuel Vidal-Taboada · 2017 · Molecular Neurobiology
  69. CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
    Dylan J. Finneran, David Morgan, Marcia N. Gordon, Kevin R. Nash · 2018 · Journal of Neuroimmune Pharmacology
  70. Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease
    Gonzalo Ruiz‐Pérez, Samuel Ruiz de Martı́n Esteban, Sharai Marqués, Noelia Aparicio, María T. Grande, Irene Benito‐Cuesta, Ana M. Martínez-Relimpio, María Andrea Arnanz, Rosa Maria Tolón, María Posada-Ayala et al. · 2021 · Journal of Neuroinflammation
  71. A Peephole into the Brain: Neuropathological Features of Alzheimer’s Disease Revealed by in vivo Two-Photon Imaging
    Sabine Liebscher, Melanie Meyer‐Luehmann · 2012 · Frontiers in Psychiatry
  72. Complex role of chemokine mediators in animal models of Alzheimer's Disease
    Elodie Martin, Cécile Delarasse · 2018 · Biomedical Journal
  73. Dysfunctional microglia and tau pathology in Alzheimer’s disease
    Gunel Ayyubova · 2022 · Reviews in the Neurosciences
  74. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer’s Disease
    Giulia Bivona, Matilda Iemmolo, Giulio Ghersi · 2023 · International Journal of Molecular Sciences
  75. Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases
    Nicole M. Desforges, Michaeline L. Hebron, Norah Khaled Algarzae, Irina Lonskaya, Charbel Moussa · 2012 · International Journal of Alzheimer s Disease
  76. Monitoring in vivo function of cortical microglia
    Bianca Brawek, Olga Garaschuk · 2017 · Cell Calcium
  77. GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease
    Lusiné Bozoyan, Julie Audoy-Rémus, Aline Dumas, Mohammed Filali, Steve Lacroix, Serge Rivest, Marie‐Ève Tremblay, Luc Vallières · 2014 · Journal of Neuroimmunology
  78. Perineuronal nets are phagocytosed by MMP‐9 expressing microglia and astrocytes in the SOD1 G93A ALS mouse model
    Sang Won Cheung, Ekta Bhavnani, David G. Simmons, Mark C. Bellingham, Peter G. Noakes · 2024 · Neuropathology and Applied Neurobiology
  79. The Fine Balance of Chemokines During Disease: Trafficking, Inflammation, and Homeostasis
    Sandra M. Cardona, Jenny A. Garcia, Astrid E. Cardona · 2013 · Methods in molecular biology
  80. Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
    Ankit Tandon, Sangh Jyoti Singh, Rajnish Kumar Chaturvedi · 2018 · BioMed Research International
  81. Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection
    Jayasri Das Sarma, Amy C Burrows, Patricia A. Rayman, Mihyun Hwang, Soumya Kundu, Nikhil Sharma, Cornelia C. Bergmann, Ganes C. Sen · 2020 · PLoS Pathogens
  82. Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators
    Ara E. Hinojosa, Javier R. Caso, Borja García‐Bueno, Juan Carlos Leza, José L. M. Madrigal · 2013 · Journal of Neuroinflammation
  83. How Many Cell Types Does It Take to Wire a Brain?
    Richard M. Ransohoff, Beth Stevens · 2011 · Science
  84. The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
    Mandana AmeliMojarad, Melika AmeliMojarad, Xiaonan Cui · 2024 · Frontiers in Aging Neuroscience
  85. How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease
    Junjun Ni, Zhen Xie, Zhenzhen Quan, Jie Meng, Hong Qing · 2023 · Glia
  86. Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer’s Disease and Its Neuropsychiatric Symptoms
    Catia Scassellati, Antonio Carlo Galoforo, Ciro Esposito, Miriam Ciani, Giovanni Ricevuti, Cristian Bonvicini · 2021 · Aging and Disease
  87. Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse
    Yongdong Zhou, Kristopher G. Sheets, Eric J. Knott, Cornelius E. Regan, Jingsheng Tuo, Chi‐Chao Chan, William C. Gordon, Nicolas Guillermo Bazan · 2011 · Experimental Eye Research
  88. Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis
    Nicolas Boivin, Rafik Menasria, David Gosselin, Serge Rivest, Guy Boivin · 2012 · Journal of General Virology
  89. Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer’s Disease
    Shanya Jiang, Kiran Bhaskar · 2017 · Journal of Alzheimer s Disease
  90. Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity
    Dworzak, Jenny, Renvoisé, Benoît, Habchi, Johnny, Yates, Emma V., Combadière, Christophe, Knowles, Tuomas P., Dobson, Christopher M., Blackstone, Craig, Paulsen, Ole, Murphy, Philip M. · 2015 · PLOS ONE
  91. Microglial Cx3cr1knockout reduces prion disease incubation time in mice
    Julia Grizenkova, Shaheen Akhtar, Sebastian Brandner, John Collinge, Sarah E. Lloyd · 2014 · BMC Neuroscience
  92. Interactions of amyloid-β peptides on lipid bilayer studied by single molecule imaging and tracking
    Chun‐Chieh Chang, Elin Edwald, Sarah L. Veatch, Duncan G. Steel, Ari Gafni · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  93. Microglia in ALS: Insights into Mechanisms and Therapeutic Potential
    Silvano Bond, Smita Saxena, Julieth A. Sierra-Delgado · 2025 · Cells
  94. Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system
    Nathalie De Vocht, Jelle Praet, Kristien Reekmans, Debbie Le Blon, Chloé Hoornaert, Jasmijn Daans, Zwi Nisan Berneman, Annemie Van der Linden, Peter Ponsaerts · 2013 · Stem Cell Research & Therapy
  95. A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix Hemorrhage in the preterm via CX3CR1+ microglia
    Jun Tang, Hongping Miao, Bing‐Hua Jiang, Qianwei Chen, Liang Tan, Yihao Tao, Jianbo Zhang, Fabao Gao, Hua Feng, Gang Zhu et al. · 2017 · Neuropharmacology
  96. Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
    Jaime M. Hatcher-Martin, J. Lucas McKay, Alyssa F. Pybus, Barbara Sommerfeld, Jennifer Christina Howell, Felicia C. Goldstein, Levi Benjamin Wood, William T. Hu, Stewart Alan Factor · 2021 · npj Parkinson s Disease
  97. Synergistic Interactions between Alzheimer’s Aβ40 and Aβ42 on the Surface of Primary Neurons Revealed by Single Molecule Microscopy
    Chun-Chieh Chang, J. Christian Althaus, Cynthia J. L. Carruthers, Michael A. Sutton, Duncan G. Steel, Ari Gafni · 2013 · PLoS ONE
  98. The Microglial Response to Neurodegenerative Disease
    Wilbur M. Song, Marco Colonna · 2018 · Advances in immunology
  99. Hypothalamic Microglial Heterogeneity and Signature under High Fat Diet–Induced Inflammation
    Natália Ferreira Mendes, Carlos Poblete Jara, Ariane Maria Zanesco, ELIANA PEREIRA DE ARAUJO · 2021 · International Journal of Molecular Sciences
  100. The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host’s Defense Strategy against Neuroinflammation
    Yosra Bedoui, Jim W. Neal, Philippe Gasque · 2018 · Journal of Neuroimmune Pharmacology